Claim · 2024-09-05 · publication · Stated in source · Supported

Google DeepMind's AlphaProteo announcement states that achieving strong binding is "usually only the first step" in designing proteins that might be useful for practical applications, and that many more bioengineering obstacles remain to be overcome in research and development.

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

AlphaProteo generates novel proteins for biology and health research → states provision → Binding stated as only a first step towards practical applications

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

AlphaProteo generates novel proteins for biology and health researchstates provision ↓Binding stated as only a first step towards practical applications

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Provision: Statement · provision ID mod-alphaproteo-limits
Date: 2024-09-05 · publication Records dated 2024 →

Scope and limitsThe company's own qualification of its announcement; it is not an independent assessment of what remains to be done.

The evidence 01

primary sourceSupports the claim

AlphaProteo generates novel proteins for biology and health research

Google DeepMind · 2024-09-05

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“Achieving strong binding is usually only the first step in designing proteins that might be useful for practical applications, and there are many more bioengineering obstacles to overcome in the research and development process.”

Location in source post, after the results section

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Protein Design and Wet Lab teams
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 09f47998d506a1da29744dbce09a0dea9c44cac8415e3adaf26f2feb7acaf539). Post dated 5 September 2024, page as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Protein Design and Wet Lab teams, “AlphaProteo generates novel proteins for biology and health research”, 2024-09-05.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (34 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.

Date. Date of the announcement.

Record ID aib-mod-alphaproteo-limits